Gables Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.36M | Buy |
2,805
+44
| +2% | +$45K | 1.22% | 21 |
|
|
2026
Q1 | $2.54M | Sell |
2,761
-64
| -2% | -$64.9K | 1.08% | 26 |
|
|
2025
Q4 | $3.04M | Buy |
2,825
+6
| +0.2% | +$5.74K | 1.28% | 20 |
|
|
2025
Q3 | $2.15M | Sell |
2,819
-80
| -3% | -$59.5K | 0.92% | 29 |
|
|
2025
Q2 | $2.26M | Buy |
2,899
+278
| +11% | +$216K | 1.07% | 27 |
|
|
2025
Q1 | $2.16M | Buy |
2,621
+164
| +7% | +$136K | 1.07% | 26 |
|
|
2024
Q4 | $1.9M | Buy |
2,457
+500
| +26% | +$414K | 0.92% | 29 |
|
|
2024
Q3 | $1.73M | Buy |
1,957
+91
| +5% | +$81.8K | 0.88% | 30 |
|
|
2024
Q2 | $1.69M | Buy |
1,866
+40
| +2% | +$32K | 0.88% | 29 |
|
|
2024
Q1 | $1.42M | Buy |
1,826
+447
| +32% | +$318K | 0.78% | 32 |
|
|
2023
Q4 | $804K | Hold |
1,379
| – | – | 0.5% | 47 |
|
|
2023
Q3 | $741K | Hold |
1,379
| – | – | 0.52% | 46 |
|
|
2023
Q2 | $647K | Hold |
1,379
| – | – | 0.42% | 53 |
|
|
2023
Q1 | $474K | Hold |
1,379
| – | – | 0.33% | 66 |
|
|
2022
Q4 | $504K | Hold |
1,379
| – | – | 0.37% | 63 |
|
|
2022
Q3 | $446K | Hold |
1,379
| – | – | 0.36% | 66 |
|
|
2022
Q2 | $447K | Buy |
1,379
+400
| +41% | +$120K | 0.34% | 69 |
|
|
2022
Q1 | $280K | Hold |
979
| – | – | 0.18% | 111 |
|
|
2021
Q4 | $270K | Hold |
979
| – | – | 0.16% | 113 |
|
|
2021
Q3 | $226K | Hold |
979
| – | – | 0.15% | 113 |
|
|
2021
Q2 | $225K | Sell |
979
-373
| -28% | -$74.9K | 0.15% | 111 |
|
|
2021
Q1 | $253K | Hold |
1,352
| – | – | 0.14% | 110 |
|
|
2020
Q4 | $228K | Hold |
1,352
| – | – | 0.13% | 106 |
|
|
2020
Q3 | $200K | Hold |
1,352
| – | – | 0.13% | 106 |
|
|
2020
Q2 | $222K | Buy |
1,352
+32
| +2% | +$4.91K | 0.15% | 102 |
|
|
2020
Q1 | $182K | Buy |
1,320
+93
| +8% | +$12.8K | 0.15% | 104 |
|
|
2019
Q4 | $160K | Hold |
1,227
| – | – | 0.11% | 131 |
|
|
2019
Q3 | $137K | Hold |
1,227
| – | – | 0.1% | 140 |
|
|
2019
Q2 | $136K | Hold |
1,227
| – | – | 0.11% | 123 |
|
|
2019
Q1 | $159K | Hold |
1,227
| – | – | 0.13% | 112 |
|
|
2018
Q4 | $142K | Hold |
1,227
| – | – | 0.12% | 114 |
|
|
2018
Q3 | $132K | Hold |
1,227
| – | – | 0.1% | 126 |
|
|
2018
Q2 | $104K | Hold |
1,227
| – | – | 0.08% | 131 |
|
|
2018
Q1 | $95K | Buy |
+1,227
| New | +$98.8K | 0.08% | 139 |
|
Other funds holding LLY
Gables Capital Management's LLY Position: Q2 2026 in Review
Gables Capital Management increased its Eli Lilly (LLY) stake by 1.6% in Q2 2026, buying an estimated $45K and bringing the position to 2,805 shares worth $3.36M. The position accounts for 1.22% of the portfolio, ranked #21.
Gables Capital Management first reported a position in LLY in Q1 2018 and has held it in 34 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Gables Capital Management held 2,805 shares of Eli Lilly worth $3.36M as of Q2 2026.
- Gables Capital Management bought 44 Eli Lilly shares in Q2 2026, an estimated $45K.
- Eli Lilly made up 1.22% of Gables Capital Management's portfolio in Q2 2026, its #21 holding.
- Gables Capital Management first reported a position in Eli Lilly in Q1 2018 and has held it in 34 quarters since.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Gables Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.